Hyderabad (Telangana) [India], April 12 (ANI): Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences R&D and clean manufacturing activities.
\
\
